Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy

Ying Xie, Tracy Murray-Stewart, Yazhe Wang, Fei Yu, Jing Li, Laurence J. Marton, Robert A. Casero, David Oupicky

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Combination of anticancer drugs with therapeutic microRNA (miRNA) has emerged as a promising anticancer strategy. However, the promise is hampered by a lack of desirable delivery systems. We report on the development of self-immolative nanoparticles capable of simultaneously delivering miR-34a mimic and targeting dysregulated polyamine metabolism in cancer. The nanoparticles were prepared from a biodegradable polycationic prodrug, named DSS-BEN, which was synthesized from a polyamine analog N1,N11-bisethylnorspermine (BENSpm). The nanoparticles were selectively disassembled in the cytoplasm where they released miRNA. Glutathione (GSH)-induced degradation of self-immolative linkers released BENSpm from the DSS-BEN polymers. MiR-34a mimic was effectively delivered to cancer cells as evidenced by upregulation of intracellular miR-34a and downregulation of Bcl-2 as one of the downstream targets of miR-34a. Intracellular BENSpm generated from the degraded nanoparticles induced the expression of rate-limiting enzymes in polyamine catabolism (SMOX, SSAT) and depleted cellular natural polyamines. Simultaneous regulation of polyamine metabolism and miR-34a expression by DSS-BEN/miR-34a not only enhanced cancer cell killing in cultured human colon cancer cells, but also improved antitumor activity in vivo. The reported findings validate the self-immolative nanoparticles as delivery vectors of therapeutic miRNA capable of simultaneously targeting dysregulated polyamine metabolism in cancer, thereby providing an elegant and efficient approach to combination nanomedicines.

Original languageEnglish (US)
Pages (from-to)110-119
Number of pages10
JournalJournal of Controlled Release
Volume246
DOIs
StatePublished - Jan 28 2017

Fingerprint

Polyamines
MicroRNAs
Nanoparticles
Neoplasms
Antineoplastic Combined Chemotherapy Protocols
Therapeutics
Nanomedicine
Prodrugs
Colonic Neoplasms
Glutathione
Polymers
Cytoplasm
Up-Regulation
Down-Regulation
Enzymes

Keywords

  • Bisethylnorspermine
  • Cancer
  • Combination delivery
  • Nanoparticles
  • Polyamine metabolism
  • Polyplexes
  • Self-immolative polymer
  • miRNA

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy. / Xie, Ying; Murray-Stewart, Tracy; Wang, Yazhe; Yu, Fei; Li, Jing; Marton, Laurence J.; Casero, Robert A.; Oupicky, David.

In: Journal of Controlled Release, Vol. 246, 28.01.2017, p. 110-119.

Research output: Contribution to journalArticle

Xie, Ying ; Murray-Stewart, Tracy ; Wang, Yazhe ; Yu, Fei ; Li, Jing ; Marton, Laurence J. ; Casero, Robert A. ; Oupicky, David. / Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy. In: Journal of Controlled Release. 2017 ; Vol. 246. pp. 110-119.
@article{d49056ff91d94f7fad2aa8b127d6334f,
title = "Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy",
abstract = "Combination of anticancer drugs with therapeutic microRNA (miRNA) has emerged as a promising anticancer strategy. However, the promise is hampered by a lack of desirable delivery systems. We report on the development of self-immolative nanoparticles capable of simultaneously delivering miR-34a mimic and targeting dysregulated polyamine metabolism in cancer. The nanoparticles were prepared from a biodegradable polycationic prodrug, named DSS-BEN, which was synthesized from a polyamine analog N1,N11-bisethylnorspermine (BENSpm). The nanoparticles were selectively disassembled in the cytoplasm where they released miRNA. Glutathione (GSH)-induced degradation of self-immolative linkers released BENSpm from the DSS-BEN polymers. MiR-34a mimic was effectively delivered to cancer cells as evidenced by upregulation of intracellular miR-34a and downregulation of Bcl-2 as one of the downstream targets of miR-34a. Intracellular BENSpm generated from the degraded nanoparticles induced the expression of rate-limiting enzymes in polyamine catabolism (SMOX, SSAT) and depleted cellular natural polyamines. Simultaneous regulation of polyamine metabolism and miR-34a expression by DSS-BEN/miR-34a not only enhanced cancer cell killing in cultured human colon cancer cells, but also improved antitumor activity in vivo. The reported findings validate the self-immolative nanoparticles as delivery vectors of therapeutic miRNA capable of simultaneously targeting dysregulated polyamine metabolism in cancer, thereby providing an elegant and efficient approach to combination nanomedicines.",
keywords = "Bisethylnorspermine, Cancer, Combination delivery, Nanoparticles, Polyamine metabolism, Polyplexes, Self-immolative polymer, miRNA",
author = "Ying Xie and Tracy Murray-Stewart and Yazhe Wang and Fei Yu and Jing Li and Marton, {Laurence J.} and Casero, {Robert A.} and David Oupicky",
year = "2017",
month = "1",
day = "28",
doi = "10.1016/j.jconrel.2016.12.017",
language = "English (US)",
volume = "246",
pages = "110--119",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

TY - JOUR

T1 - Self-immolative nanoparticles for simultaneous delivery of microRNA and targeting of polyamine metabolism in combination cancer therapy

AU - Xie, Ying

AU - Murray-Stewart, Tracy

AU - Wang, Yazhe

AU - Yu, Fei

AU - Li, Jing

AU - Marton, Laurence J.

AU - Casero, Robert A.

AU - Oupicky, David

PY - 2017/1/28

Y1 - 2017/1/28

N2 - Combination of anticancer drugs with therapeutic microRNA (miRNA) has emerged as a promising anticancer strategy. However, the promise is hampered by a lack of desirable delivery systems. We report on the development of self-immolative nanoparticles capable of simultaneously delivering miR-34a mimic and targeting dysregulated polyamine metabolism in cancer. The nanoparticles were prepared from a biodegradable polycationic prodrug, named DSS-BEN, which was synthesized from a polyamine analog N1,N11-bisethylnorspermine (BENSpm). The nanoparticles were selectively disassembled in the cytoplasm where they released miRNA. Glutathione (GSH)-induced degradation of self-immolative linkers released BENSpm from the DSS-BEN polymers. MiR-34a mimic was effectively delivered to cancer cells as evidenced by upregulation of intracellular miR-34a and downregulation of Bcl-2 as one of the downstream targets of miR-34a. Intracellular BENSpm generated from the degraded nanoparticles induced the expression of rate-limiting enzymes in polyamine catabolism (SMOX, SSAT) and depleted cellular natural polyamines. Simultaneous regulation of polyamine metabolism and miR-34a expression by DSS-BEN/miR-34a not only enhanced cancer cell killing in cultured human colon cancer cells, but also improved antitumor activity in vivo. The reported findings validate the self-immolative nanoparticles as delivery vectors of therapeutic miRNA capable of simultaneously targeting dysregulated polyamine metabolism in cancer, thereby providing an elegant and efficient approach to combination nanomedicines.

AB - Combination of anticancer drugs with therapeutic microRNA (miRNA) has emerged as a promising anticancer strategy. However, the promise is hampered by a lack of desirable delivery systems. We report on the development of self-immolative nanoparticles capable of simultaneously delivering miR-34a mimic and targeting dysregulated polyamine metabolism in cancer. The nanoparticles were prepared from a biodegradable polycationic prodrug, named DSS-BEN, which was synthesized from a polyamine analog N1,N11-bisethylnorspermine (BENSpm). The nanoparticles were selectively disassembled in the cytoplasm where they released miRNA. Glutathione (GSH)-induced degradation of self-immolative linkers released BENSpm from the DSS-BEN polymers. MiR-34a mimic was effectively delivered to cancer cells as evidenced by upregulation of intracellular miR-34a and downregulation of Bcl-2 as one of the downstream targets of miR-34a. Intracellular BENSpm generated from the degraded nanoparticles induced the expression of rate-limiting enzymes in polyamine catabolism (SMOX, SSAT) and depleted cellular natural polyamines. Simultaneous regulation of polyamine metabolism and miR-34a expression by DSS-BEN/miR-34a not only enhanced cancer cell killing in cultured human colon cancer cells, but also improved antitumor activity in vivo. The reported findings validate the self-immolative nanoparticles as delivery vectors of therapeutic miRNA capable of simultaneously targeting dysregulated polyamine metabolism in cancer, thereby providing an elegant and efficient approach to combination nanomedicines.

KW - Bisethylnorspermine

KW - Cancer

KW - Combination delivery

KW - Nanoparticles

KW - Polyamine metabolism

KW - Polyplexes

KW - Self-immolative polymer

KW - miRNA

UR - http://www.scopus.com/inward/record.url?scp=85007416069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007416069&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2016.12.017

DO - 10.1016/j.jconrel.2016.12.017

M3 - Article

C2 - 28017891

AN - SCOPUS:85007416069

VL - 246

SP - 110

EP - 119

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -